The Economist’s health care correspondent, Natasha Loder, delves into the status and future of cancer treatment in this incredibly thorough report. She focuses on the science, biotechnology and economics behind treating this deadly disease. While the subject matter is technical and complex, the piece is a fascinating look at one patient’s story, set against the background of extensive research and development of new strategies in the cancer world. getAbstract recommends this article to anyone in biotechnology, as well as physicians, scientists, and those whose lives have been touched by cancer.
In this summary, you will learn
- What the state of cancer therapy is worldwide,
- How scientists and clinicians harness the immune system to attack cancer, and
- What the future of cancer research, development and treatment holds, both medically and financially.
About the Author
Natasha Loder is the health care correspondent for The Economist. She writes about biotechnology, medical science and the pharmaceutical industry.